Mint Pharmaceuticals Inc. (“Mint”) is a leading generic pharmaceutical manufacturer of high quality and affordable generic pharmaceutical products to the Canadian market. With focus on consistent supply, innovation and exceptional customer service, Mint aims to deliver the highest value to Canadian patients. Canadian owned and operated company, Mint has repeatedly been recognized as one of the fastest growing generic pharmaceutical companies in Canada, according to IQVIA and one of the most reputable generic manufacturers in Canada by Advantage Survey. Since 2014, the company has averted 15 national drug shortages on 10 different critical medications through our best in class supply chain management. Since 2019, Mint has been recognized as one of Canada’s Best Managed Companies by Deloitte and CIBC.

YPO (formerly Young Presidents' Organization) is a global network of young chief executives with approximately 26,000 members in more than 130 countries.